Published in Adv Exp Med Biol on January 01, 2008
A comprehensive catalogue of somatic mutations from a human cancer genome. Nature (2009) 24.27
Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease. Clin Gastroenterol Hepatol (2010) 2.80
Nonmelanoma skin cancer in inflammatory bowel disease: a review. Inflamm Bowel Dis (2010) 2.36
The role of vitamin D in cancer prevention: does UV protection conflict with the need to raise low levels of vitamin D? Dtsch Arztebl Int (2010) 1.96
Wounding enhances epidermal tumorigenesis by recruiting hair follicle keratinocytes. Proc Natl Acad Sci U S A (2011) 1.89
UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer. Photochem Photobiol Sci (2011) 1.51
Wild carrot pentane-based fractions suppress proliferation of human HaCaT keratinocytes and protect against chemically-induced skin cancer. BMC Complement Altern Med (2017) 1.39
UV radiation and the skin. Int J Mol Sci (2013) 1.37
Anticancer and cancer chemopreventive potential of grape seed extract and other grape-based products. J Nutr (2009) 1.33
A new understanding in the epidemiology of melanoma. Expert Rev Anticancer Ther (2010) 1.30
Environmental exposures and mutational patterns of cancer genomes. Genome Med (2010) 1.29
Prospective study of ultraviolet radiation exposure and risk of cancer in the United States. Int J Cancer (2012) 1.23
Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Res Ther (2011) 1.23
Epigenetically reprogramming metastatic tumor cells with an embryonic microenvironment. Epigenomics (2009) 1.22
Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma. Cell Cycle (2008) 1.20
Melanocytes are deficient in repair of oxidative DNA damage and UV-induced photoproducts. Proc Natl Acad Sci U S A (2010) 1.11
The side effects of phototherapy for neonatal jaundice: what do we know? What should we do? Eur J Pediatr (2011) 1.04
Dissecting the bulge in hair regeneration. J Clin Invest (2012) 1.03
Human skin pigmentation, migration and disease susceptibility. Philos Trans R Soc Lond B Biol Sci (2012) 1.01
The relationship between occupational sun exposure and non-melanoma skin cancer: clinical basics, epidemiology, occupational disease evaluation, and prevention. Dtsch Arztebl Int (2012) 1.00
The genomic landscape of childhood and adolescent melanoma. J Invest Dermatol (2014) 0.99
Transcription-dependent cytosine deamination is a novel mechanism in ultraviolet light-induced mutagenesis. Curr Biol (2009) 0.98
Clinicopathological evaluation of nonmelanoma skin cancer. Indian J Dermatol (2011) 0.97
Inflammatory signaling compromises cell responses to interferon alpha. Oncogene (2011) 0.96
Vitamin D and the epidemiology of upper gastrointestinal cancers: a critical analysis of the current evidence. Cancer Epidemiol Biomarkers Prev (2013) 0.96
TERT promoter mutations are frequent in cutaneous basal cell carcinoma and squamous cell carcinoma. PLoS One (2013) 0.95
Cumulative ultraviolet radiation flux in adulthood and risk of incident skin cancers in women. Br J Cancer (2014) 0.92
Mailed intervention to promote sun protection of children: a randomized controlled trial. Am J Prev Med (2012) 0.91
Overexpression of Chromatin Assembly Factor-1/p60 helps to predict the prognosis of melanoma patients. BMC Cancer (2010) 0.90
Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis. Br J Cancer (2010) 0.89
New malignancies after squamous cell carcinoma and melanomas: a population-based study from Norway. BMC Cancer (2014) 0.87
Signaling Pathways in Melanogenesis. Int J Mol Sci (2016) 0.87
A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important. Pigment Cell Melanoma Res (2012) 0.87
Epidemiology of skin cancer: role of some environmental factors. Cancers (Basel) (2010) 0.87
Chemoprevention of chemical-induced skin cancer by Panax ginseng root extract. J Ginseng Res (2015) 0.87
Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk. Neurology (2013) 0.86
UVA and UVB irradiation differentially regulate microRNA expression in human primary keratinocytes. PLoS One (2013) 0.86
Factors associated with risky sun exposure behaviors among operating engineers. Am J Ind Med (2012) 0.86
Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. Eur J Cancer (2010) 0.84
Melanoma prevention using topical PBISe. Cancer Prev Res (Phila) (2011) 0.84
Kaempferol targets RSK2 and MSK1 to suppress UV radiation-induced skin cancer. Cancer Prev Res (Phila) (2014) 0.83
The relation between dermoscopy and histopathology of basal cell carcinoma. An Bras Dermatol (2015) 0.83
The impact of comorbidity and stage on prognosis of Danish melanoma patients, 1987-2009: a registry-based cohort study. Br J Cancer (2013) 0.82
Arg72Pro polymorphism of TP53 gene and the risk of skin cancer: a meta-analysis. PLoS One (2013) 0.81
Endogenous Nodal promotes melanoma undergoing epithelial-mesenchymal transition via Snail and Slug in vitro and in vivo. Am J Cancer Res (2015) 0.81
HOX Gene Aberrant Expression in Skin Melanoma: A Review. J Skin Cancer (2012) 0.81
Role of SKP1-CUL1-F-box-protein (SCF) E3 ubiquitin ligases in skin cancer. J Genet Genomics (2013) 0.81
Prognostic and risk factors in patients with locally advanced cutaneous squamous cell carcinoma of the trunk and extremities. J Skin Cancer (2011) 0.80
Changes in skin tanning attitudes. Fashion articles and advertisements in the early 20th century. Am J Public Health (2009) 0.80
Cancer incidence in a cohort of Swedish chimney sweeps, 1958-2006. Am J Public Health (2013) 0.80
XRCC3 C18067T polymorphism contributes a decreased risk to both basal cell carcinoma and squamous cell carcinoma: evidence from a meta-analysis. PLoS One (2014) 0.80
A majority of human melanoma cell lines exhibits an S phase-specific defect in excision of UV-induced DNA photoproducts. PLoS One (2014) 0.80
Risk factors in Central Poland for the development of superficial and nodular basal cell carcinomas. Arch Med Sci (2010) 0.80
Melanoma incidence rates among whites in the U.S. Military. Cancer Epidemiol Biomarkers Prev (2010) 0.80
The incidence of nonmelanoma skin cancers and actinic keratoses in South Florida. J Clin Aesthet Dermatol (2012) 0.79
The Epidemiology of Skin Cancer and its Trend in Iran. Int J Prev Med (2015) 0.79
Size is an essential parameter in governing the UVB-protective efficacy of silver nanoparticles in human keratinocytes. BMC Cancer (2015) 0.78
Geography of non-melanoma skin cancer and ecological associations with environmental risk factors in England. Br J Cancer (2013) 0.78
Reserpine Inhibit the JB6 P+ Cell Transformation Through Epigenetic Reactivation of Nrf2-Mediated Anti-oxidative Stress Pathway. AAPS J (2016) 0.78
Pattern of Nonmelanoma Skin Cancers in Sikkim, India: A 3-year Clinicopathological Review. Indian J Otolaryngol Head Neck Surg (2013) 0.77
Basal cell carcinoma of the head and neck region: a retrospective analysis of completely excised 331 cases. J Skin Cancer (2014) 0.77
Contribution of glutathione S-transferase gene polymorphisms to development of skin cancer. Int J Clin Exp Med (2015) 0.77
Development and Characterization of a Novel in vitro Progression Model for UVB-Induced Skin Carcinogenesis. Sci Rep (2015) 0.77
Differential expression of degradome components in cutaneous squamous cell carcinomas. Mod Pathol (2013) 0.77
Ultraviolet light and skin cancer in athletes. Sports Health (2009) 0.77
In vivo skin fluorescence imaging in young Caucasian adults with early malignant melanomas. Clin Cosmet Investig Dermatol (2014) 0.76
Is open surgery for head and neck cancers truly declining? Eur Arch Otorhinolaryngol (2013) 0.76
Comparative analysis of the relative potential of silver, Zinc-oxide and titanium-dioxide nanoparticles against UVB-induced DNA damage for the prevention of skin carcinogenesis. Cancer Lett (2016) 0.76
Application of Multiphoton Microscopy in Dermatological Studies: a Mini-Review. J Innov Opt Health Sci (2014) 0.76
Topical delivery of silymarin constituents via the skin route. Acta Pharmacol Sin (2009) 0.76
Management of locoregional recurrence in cutaneous squamous cell carcinoma of the head and neck. Eur Arch Otorhinolaryngol (2016) 0.75
Safety and Efficacy of Transplantation with Allogeneic Skin Tumors to Treat Chemically-Induced Skin Tumors in Mice. Med Sci Monit (2016) 0.75
Association of CRR9 locus with elevated risk of squamous cell carcinoma and basal cell carcinoma. Int J Clin Exp Med (2015) 0.75
Thin and thick primary cutaneous melanomas reveal distinct patterns of somatic copy number alterations. Oncotarget (2016) 0.75
A Comparative Study Examining the Management of Bowen's Disease in the United Kingdom and Australia. Dermatol Res Pract (2015) 0.75
Establishing Human Skin Grafts in Mice as Model for Melanoma Progression. Methods Mol Biol (2015) 0.75
A somatic reference standard for cancer genome sequencing. Sci Rep (2016) 0.75
Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis. Oncotarget (2016) 0.75
Appearances may be deceiving. Dermatol Pract Concept (2016) 0.75
Epidemiological trends in skin cancer. Dermatol Pract Concept (2017) 0.75
Commentary: Chemiexcitation of melanin derivatives induces DNA photoproducts long after UV exposure. Front Physiol (2015) 0.75
The author's reply. Am J Epidemiol (2013) 0.75
Protocol of a randomized controlled trial of sun protection interventions for operating engineers. BMC Public Health (2013) 0.75
How to correct frontal facialis palsy after radical tumour surgery: upper blepharoplasty and direct brow lift. J Cutan Aesthet Surg (2011) 0.75
Diagnostic dilemma; report of a bizarre case of advanced scalp and face angiosarcoma and literature review. Int Med Case Rep J (2011) 0.75
Is there truly no benefit with sunscreen use and Basal cell carcinoma? A critical review of the literature and the application of new sunscreen labeling rules to real-world sunscreen practices. J Skin Cancer (2012) 0.75
Prospective study of physical activity and risk of squamous cell carcinoma of the skin. BMC Cancer (2011) 0.75
A retrospective analysis of occupational exposure to pesticides as a possible risk factor for non-melanoma skin cancers. South Asian J Cancer (2015) 0.75
Differential expression of tetraspanin CD9 in basal cell and squamous cell carcinomas of the skin and actinic keratosis. Oncol Lett (2010) 0.75
Epidemiology and trend in skin cancer mortality in Iran. J Res Med Sci (2015) 0.75
Residential Radon Exposure and Skin Cancer Incidence in a Prospective Danish Cohort. PLoS One (2015) 0.75
Oculoplastic aspects of ocular oncology. Eye (Lond) (2012) 0.75
Generation of metastatic melanoma specific antibodies by affinity purification. Sci Rep (2016) 0.75
Destroying c-jun Messenger: new insights into biological mechanisms of DNAzyme function. Oncotarget (2012) 0.75
Ultraviolet radiation and the slug transcription factor induce proinflammatory and immunomodulatory mediator expression in melanocytes. J Skin Cancer (2012) 0.75
The association between TP53 Arg72pro polymorphism and non-melanoma skin cancer risk: a meta-analysis including 7,107 subjects. Indian J Dermatol (2013) 0.75
XRCC3 T241M polymorphism and melanoma skin cancer risk: A meta-analysis. Oncol Lett (2015) 0.75
Cutaneous HPV8 and MmuPV1 E6 Proteins Target the NOTCH and TGF-β Tumor Suppressors to Inhibit Differentiation and Sustain Keratinocyte Proliferation. PLoS Pathog (2017) 0.75
Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med (2011) 45.46
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma. N Engl J Med (2011) 26.90
Improved survival with MEK inhibition in BRAF-mutated melanoma. N Engl J Med (2012) 11.72
Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with carboplatin and paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma. J Clin Oncol (2009) 6.44
Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. N Engl J Med (2014) 5.43
Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma. J Clin Oncol (2013) 5.36
Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma. N Engl J Med (2014) 4.71
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
Improving melanoma classification by integrating genetic and morphologic features. PLoS Med (2008) 2.52
Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib. Oncologist (2008) 2.22
Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up. Cancer Immunol Immunother (2010) 2.18
The price of tumor control: an analysis of rare side effects of anti-CTLA-4 therapy in metastatic melanoma from the ipilimumab network. PLoS One (2013) 2.01
The RAS/RAF/MEK/ERK and PI3K/AKT signaling pathways present molecular targets for the effective treatment of advanced melanoma. Front Biosci (2005) 2.00
Functional T cells targeting NY-ESO-1 or Melan-A are predictive for survival of patients with distant melanoma metastasis. J Clin Oncol (2012) 1.97
Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. Lancet Oncol (2003) 1.78
Combined inhibition of MAPK and mTOR signaling inhibits growth, induces cell death, and abrogates invasive growth of melanoma cells. J Invest Dermatol (2008) 1.71
Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer (2010) 1.66
The natural course of cutaneous melanoma. J Surg Oncol (2004) 1.56
Sentinel lymph node dissection in primary melanoma reduces subsequent regional lymph node metastasis as well as distant metastasis after nodal involvement. Ann Surg Oncol (2009) 1.49
Age and gender are significant independent predictors of survival in primary cutaneous melanoma. Cancer (2008) 1.49
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol (2002) 1.47
Direct injection of protamine-protected mRNA: results of a phase 1/2 vaccination trial in metastatic melanoma patients. J Immunother (2009) 1.44
Myeloid-derived suppressor cells predict survival of patients with advanced melanoma: comparison with regulatory T cells and NY-ESO-1- or melan-A-specific T cells. Clin Cancer Res (2013) 1.43
Adjuvant treatment with vindesine in comparison to observation alone in patients with metastasized melanoma after complete metastasectomy: a randomized multicenter trial of the German Dermatologic Cooperative Oncology Group. Melanoma Res (2008) 1.40
Results of the first phase I/II clinical vaccination trial with direct injection of mRNA. J Immunother (2008) 1.40
The prevalence of human papillomavirus genotypes in nonmelanoma skin cancers of nonimmunosuppressed individuals identifies high-risk genital types as possible risk factors. Cancer Res (2003) 1.37
Inhibition of PI3K-AKT-mTOR signaling sensitizes melanoma cells to cisplatin and temozolomide. J Invest Dermatol (2008) 1.35
Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer (2007) 1.30
The incidence and mortality of cutaneous melanoma in Southern Germany: trends by anatomic site and pathologic characteristics, 1976 to 2003. Cancer (2006) 1.30
Dermoscopy of tungiasis. Arch Dermatol (2004) 1.29
Epidemiology of skin cancer. Adv Exp Med Biol (2014) 1.29
Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group. J Clin Oncol (2005) 1.27
β-Catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One (2011) 1.25
Malignant melanoma S3-guideline "diagnosis, therapy and follow-up of melanoma". J Dtsch Dermatol Ges (2013) 1.25
Suppression of casein kinase 1alpha in melanoma cells induces a switch in beta-catenin signaling to promote metastasis. Cancer Res (2010) 1.23
Desmoplastic malignant melanoma: a clinicopathologic analysis of 113 cases. Am J Dermatopathol (2008) 1.20
Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells. Sci Signal (2013) 1.19
Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer Med (2013) 1.19
Non-AIDS associated Kaposi's sarcoma: clinical features and treatment outcome. PLoS One (2011) 1.19
Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society. J Clin Oncol (2004) 1.18
Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed? Cancer (2007) 1.17
Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. Int J Dermatol (2011) 1.17
Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol (2005) 1.16
Efficacy of low-dose interferon {alpha}2a 18 versus 60 months of treatment in patients with primary melanoma of >= 1.5 mm tumor thickness: results of a randomized phase III DeCOG trial. J Clin Oncol (2010) 1.14
Cathepsin D is present in human eccrine sweat and involved in the postsecretory processing of the antimicrobial peptide DCD-1L. J Biol Chem (2005) 1.12
The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. Int J Cancer (2007) 1.10
Acquired melanocytic nevi as risk factor for melanoma development. A comprehensive review of epidemiological data. Pigment Cell Res (2003) 1.09
Risk factors of incident melanocytic nevi: a longitudinal study in a cohort of 1,232 young German children. Int J Cancer (2005) 1.08
Moderate sun exposure and nevus counts in parents are associated with development of melanocytic nevi in childhood: a risk factor study in 1,812 kindergarten children. Cancer (2003) 1.08
High response rate after intratumoral treatment with interleukin-2: results from a phase 2 study in 51 patients with metastasized melanoma. Cancer (2010) 1.07
Plasmid DNA- and messenger RNA-based anti-cancer vaccination. Immunol Lett (2007) 1.07
Costs of the detection of metastases and follow-up examinations in cutaneous melanoma. Melanoma Res (2009) 1.05
Multicenter phase II trial of the histone deacetylase inhibitor pyridylmethyl-N-{4-[(2-aminophenyl)-carbamoyl]-benzyl}-carbamate in pretreated metastatic melanoma. Melanoma Res (2008) 1.05
Exclusion of BRAFV599E as a melanoma susceptibility mutation. Int J Cancer (2003) 1.04
Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Melanoma Res (2011) 1.01
Truncation of activated leukocyte cell adhesion molecule: a gateway to melanoma metastasis. J Invest Dermatol (2004) 1.00
Incisional biopsy and melanoma prognosis: Facts and controversies. Clin Dermatol (2010) 0.99
Generation of multiple stable dermcidin-derived antimicrobial peptides in sweat of different body sites. J Invest Dermatol (2006) 0.99
Serum S100B, lactate dehydrogenase and brain metastasis are prognostic factors in patients with distant melanoma metastasis and systemic therapy. PLoS One (2013) 0.97
Prospective comparison of the impact on treatment decisions of whole-body magnetic resonance imaging and computed tomography in patients with metastatic malignant melanoma. Eur J Cancer (2005) 0.96
A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. Clin Cancer Res (2011) 0.96
Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma. J Clin Oncol (2006) 0.95
Short German guidelines: dermatofibrosarcoma protuberans. J Dtsch Dermatol Ges (2008) 0.95
The farnesyl transferase inhibitor lonafarnib inhibits mTOR signaling and enforces sorafenib-induced apoptosis in melanoma cells. J Invest Dermatol (2010) 0.94
Effectiveness of carboplatin and paclitaxel as first- and second-line treatment in 61 patients with metastatic melanoma. PLoS One (2011) 0.94
Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. J Clin Oncol (2010) 0.93
The adhesion molecule L1 (CD171) promotes melanoma progression. Int J Cancer (2006) 0.93
"Functional" surgery in subungual melanoma. Dermatol Surg (2003) 0.93
Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients with advanced melanoma. J Clin Oncol (2013) 0.92
Cytotoxicity of new duplex drugs linking 3'-C-ethynylcytidine and 5-fluor-2'-deoxyuridine against human melanoma cells. Int J Cancer (2012) 0.92
Sex differences in survival of cutaneous melanoma are age dependent: an analysis of 7338 patients. Melanoma Res (2011) 0.91
Short German guidelines: basal cell carcinoma. J Dtsch Dermatol Ges (2008) 0.91
[Psychosocial burden and subjective experience of melanoma patients in the ambulant follow-up]. Psychother Psychosom Med Psychol (2003) 0.90
Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res (2010) 0.90
Effect of sunscreen and clothing on the number of melanocytic nevi in 1,812 German children attending day care. Am J Epidemiol (2005) 0.90
The stepwise two-photon excited melanin fluorescence is a unique diagnostic tool for the detection of malignant transformation in melanocytes. Pigment Cell Melanoma Res (2011) 0.89
Modified ABC-point list of dermoscopy: A simplified and highly accurate dermoscopic algorithm for the diagnosis of cutaneous melanocytic lesions. J Am Acad Dermatol (2003) 0.89
Hazard rates for recurrent and secondary cutaneous melanoma: an analysis of 33,384 patients in the German Central Malignant Melanoma Registry. J Am Acad Dermatol (2011) 0.89
Radiation recall dermatitis and radiation pneumonitis during treatment with vemurafenib. Melanoma Res (2014) 0.89
S3-guideline "diagnosis, therapy and follow-up of melanoma" -- short version. J Dtsch Dermatol Ges (2013) 0.88
Detection of dermcidin-derived peptides in sweat by ProteinChip technology. J Immunol Methods (2002) 0.87
Fibroblast growth factor-2 but not Mel-CAM and/or beta3 integrin promotes progression of melanocytes to melanoma. Exp Dermatol (2003) 0.87
Short German guidelines: Merkel cell carcinoma. J Dtsch Dermatol Ges (2008) 0.87
Management of pegylated interferon alpha toxicity in adjuvant therapy of melanoma. Expert Opin Biol Ther (2012) 0.87
Management of cutaneous side effects of EGFR inhibitors: recommendations from a German expert panel for the primary treating physician. J Dtsch Dermatol Ges (2010) 0.87
Melanoma staging: facts and controversies. Clin Dermatol (2010) 0.86
Is detection of melanoma metastasis during surveillance in an early phase of development associated with a survival benefit? Melanoma Res (2010) 0.86
Isotopic response of graft versus host disease following herpes zoster infection: case report and review of the literature. Acta Derm Venereol (2012) 0.86
Blue light phototherapy of neonatal jaundice does not increase the risk for melanocytic nevus development. Arch Dermatol (2004) 0.85
Recurrent nodules in a periauricular plaque-type blue nevus with fatal outcome. J Cutan Pathol (2012) 0.85
Extramammary Paget's disease: extended subclinical growth detected using three-dimensional histology in routine paraffin procedure and course of the disease. Dermatol Surg (2011) 0.85
Brief S2k guidelines--Basal cell carcinoma of the skin. J Dtsch Dermatol Ges (2013) 0.85
Noggin blocks invasive growth of murine B16-F1 melanoma cells in the optic cup of the chick embryo. Int J Cancer (2008) 0.84
A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. J Am Acad Dermatol (2007) 0.84
Interventional study in 1,232 young German children to prevent the development of melanocytic nevi failed to change sun exposure and sun protective behavior. Int J Cancer (2005) 0.84
CHEK2*1100delC and risk of malignant melanoma: Danish and German studies and meta-analysis. J Invest Dermatol (2011) 0.83
Production and characterization of amplified tumor-derived cRNA libraries to be used as vaccines against metastatic melanomas. Genet Vaccines Ther (2005) 0.83